Pharmafile Logo
Pharmafocus logo
Advanced Search

PEP-Therapy and Institut Curie’s cancer drug trial approved in France

March 17, 2021
Research and Development Cancer, France, Pep-therapy

PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …

News

Medicago & GSK start plant-derived COVID-19 vaccine trial

March 17, 2021
Research and Development COVID-19, GSK

Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …

News
Janssen sign

Johnson & Johnson’s arthritis drug shows promising results in Phase III trial

March 16, 2021
Manufacturing and Production Janssen, Johnson & Johnson, PSA, Tremfya, arthritis

Johnson & Johnson’s TREMFYA treatment for active Psoriatic Arthritis (PsA) has returned positive results in its Phase III trial.

News

Roche and PTC’s SMA treatment shows positive trial results

March 16, 2021
Manufacturing and Production PTC, PTC Therapeutics, Roche, sma, spinal muscular atrophy

Roche and PTC Therapeutics’s Evrysdi treatment for children and adults with Type 2 or Type 3 spinal muscular atrophy (SMA) …

News
az

AstraZeneca vaccine suspended in 11 European countries

March 16, 2021
Manufacturing and Production AstraZeneca

Blood clot fears have caused 11 European countries to suspend the use of the Oxford-AstraZeneca vaccine. France, Germany, Italy, and …

News
gilead-sciences

Gilead and MSD partner to develop and commercialise two-drug HIV regimen

March 16, 2021
Manufacturing and Production Gilead, HIV, MSD

Gilead and MSD, known as Merck in the US and Canada, have entered into an agreement to co-develop and co-commercialise …

News

Perception and Otsuka enter collaboration and licensing deal for depression drug candidate

March 16, 2021
Manufacturing and Production CNS, Otsuka Pharmaceutical, Perception Neuroscience, depression

Perception Neuroscience and Otsuka Pharmaceutical have announced a collaboration and licensing agreement for the development and commercialisation of Perception’s lead …

News
A woman being given eye drops

Ocuphire’s pupil dilation treatment shows promising Phase III trial results

March 15, 2021
Sales and Marketing Ocuphire, eye treatment, nyxol

Ocuphire Pharma’s Nyxol treatment for pharmacologically-induced pupil dilation (mydriasis) has met its primary and secondary endpoints in its Phase III …

News
brain_scan_small

Newron and Zambon to collaborate on Parkinson’s dyskinesia drug trial

March 15, 2021
Sales and Marketing Newron Pharmaceuticals, Parkinson's, Zambon

Newron Pharmaceuticals and its partner Zambon have announced an agreement for a potentially pivotal study to evaluate the efficacy of …

News
Roche building

Roche acquire GenMark in $1.8 billion deal

March 15, 2021
Sales and Marketing Diagnostics, GenMark, Roche

Pharmaceutical giant Roche have bought GenMark Diagnostics in a deal worth $1.8 billion, expanding their infectious disease testing for illnesses …

News
astrazeneca_sign_sky

Netherlands suspends AstraZeneca vaccine despite safety assurances

March 15, 2021
Medical Communications, Sales and Marketing AstraZeneca, COVID-19, EMA, EU, WHO

The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause …

News
libtayo

Phase III trial of Libtayo stopped early after positive overall survival results

March 15, 2021
Sales and Marketing Cancer, Libtayo, Regeneron, Sanofi

A Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo (cemiplimab) will be stopped early after positive results demonstrated …

News
top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

March 12, 2021
Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news

In the last week, a number of new treatment developments have made the news; for COVID-19, GSK and Vir’s monoclonal-antibody …

News

Kintor’s COVID-19 treatment reduces mortality by 92%

March 12, 2021
Medical Communications Brazil, Brazil variant, COVID-19, Kintor, covid-19 treatment

Kintor Pharmaceutical’s Proxalutamide treatment has been proven to reduce risk of mortality from COVID-19 by 92%, in a clinical trial …

News

J&J’s one-shot COVID-19 vaccine approved by European Commission

March 12, 2021
Medical Communications COVID-19, EMA, Johnson & Johnson

The European Commission has granted Johnson and Johnson’s single-shot COVID-19 vaccine Conditional Marketing Authorisation (CMA), it was announced on Thursday. …

News

Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains

March 12, 2021
Medical Communications COVID-19, Novavax, vaccines

Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in …

News
lonza

Altimmune expands COVID-19 vaccine manufacturing deal with Lonza

March 12, 2021
Medical Communications Altimmune, COVID-19, Lonza, vaccines

Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …

News
Eli Lilly building

Eli Lilly’s COVID-19 treatment combination 87% effective in Phase III trial

March 11, 2021
COVID-19, Eli Lilly, covid-19 treatment

Eli Lilly has shown positive results in its Phase III combination drug trial, which reduced hospitalisations and deaths related to …

News
GSK building

GSK and Vir Biotechnology COVID-19 drug found to reduce deaths and hospitalisation by 85%

March 11, 2021
GSK, GlaxoSmithKline, Vir Biotechnology

Vir Biotechnology and GSK have announced that their monoclonal-antibody drug has been found to reduce hospitalisations or deaths from COVID-19 …

News
FDA building

FDA approves AVEO’s kidney cancer treatment

March 11, 2021
Aveo, FDA, Kidney cancer, fotivda, rcc

The FDA has approved AVEO Oncology’s FOTIVDA drug for the treatment of adults with relapsed or refractory advanced renal cell …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026